Science Explorer Back to mapMap
Discussion
Researcher · Tashkent Medical Academy · Uzbekistan

Iskandar Mavlyanov

Iskandar Mavlyanov publishes mostly in Genetics, Rheumatology and Radiology, Nuclear Medicine and Imaging, on topics such as Genetics and Physical Performance, Human Health and Disease and Rheumatoid Arthritis Research and Therapies.

ORCID 0000-0001-8723-3971 OpenAlex
World rank
#5,910,569
of 7,710,434 ranked researchers
Rank in Uzbekistan
#1,438
of 3,371
Works
15
Citations
16
Citations per work
1.1
h-index
2
i10-index 1Top 98% in Genetics (Biochemistry, Genetics and Molecular Biology)
Iskandar Mavlyanov

What does Iskandar Mavlyanov research?

Iskandar Mavlyanov's work is mostly in Medicine (44%), Biochemistry, Genetics and Molecular Biology (15%).

Health Sciences: 7 works · 43.6% of their workMedicine: 7 works · 43.6% of their workRheumatology: 2 works · 12.8% of their workRadiology, Nuclear Medicine and Imaging: 2 works · 10.3% of their workPediatrics, Perinatology and Child Health: 1 works · 7.7% of their workPharmacology: 1 works · 7.7% of their workInfectious Diseases: 1 works · 5.1% of their workEverything else: 6 works · 41.0% of their workLife Sciences: 2 works · 15.4% of their workBiochemistry, Genetics and Molecular Biology: 2 works · 15.4% of their workGenetics: 2 works · 15.4% of their workTHEIR WORKIskandarMavlyanov15works
Life Sciences15%Health Sciences44%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
    1. Medicine743.6%
  2. Everything else641.0%
    1. Biochemistry, Genetics and Molecular Biology215.4%
  1. 1Genetics15% of their works
  2. 2Rheumatology13% of their works
  3. 3Radiology, Nuclear Medicine and Imaging10% of their works
  4. 4Pediatrics, Perinatology and Child Health8% of their works
  5. 5Pharmacology8% of their works
  6. 6Infectious Diseases5% of their works

Research topics

Which keywords describe Iskandar Mavlyanov's research?

The keywords of their largest research topics: Nutrition, ACE Gene, ACTN3 Genotype, Child Health, Inflammation, Rheumatoid Arthritis, Risk Assessment and Anatomical Nomenclature.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.

All 17 words, with their numbers
  1. Nutrition42 topics
  2. ACE Gene31 topic
  3. ACTN3 Genotype31 topic
  4. Child Health31 topic
  5. Inflammation31 topic
  6. Rheumatoid Arthritis31 topic
  7. Risk Assessment31 topic
  8. Anatomical Nomenclature21 topic
  9. Dermatoglyphic Patterns21 topic
  10. Eponyms21 topic
  11. Fc Receptors21 topic
  12. Genetic Marker21 topic
  13. HLA-B*570121 topic
  14. Stevens-Johnson Syndrome21 topic
  15. Therapeutic Antibodies21 topic
  16. Climate Change11 topic
  17. Food Security11 topic

Where does Iskandar Mavlyanov work?

Iskandar Mavlyanov's main affiliation in the publication record is Tashkent Medical Academy, Uzbekistan.

How many publications and citations does Iskandar Mavlyanov have?

OpenAlex counts 15 works and 16 citations for Iskandar Mavlyanov, an h-index of 2, ranking #5,910,569 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Iskandar Mavlyanov. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.